SCHEMBL4696335

SCHEMBL4696335

O=C(CNCCOC(=O)N(c1ccccc1-c1ccccc1)N1CC[CH]CC1)c1ccc(CNCCO)cc1

nearest known ligand 0.44

Predicted protein targets (top 6)

geneUniProtsupporting neighboursconfidence
PDCD1 Q15116 16/20 0.44
CD274 Q9NZQ7 16/20 0.44
SMN1; SMN2 Q16637 2/20 0.36
HTT P42858 1/20 0.35
LTA4H P09960 1/20 0.34
ALDH1A1 P00352 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4692560 0.93 CD274 (0.39) PDCD1CD274LTA4H
SCHEMBL4691952 0.92 PDCD1 (0.35) PDCD1CD274LTA4HALDH1A1
SCHEMBL6027383 0.91 OPRM1 (0.36) PDCD1CD274ALDH1A1
SCHEMBL4697200 0.91 HDAC1 (0.37) PDCD1CD274ALDH1A1
SCHEMBL4695511 0.90 PDCD1 (0.34) PDCD1CD274SMN1; SMN2HTT
SCHEMBL4696628 0.89 HDAC1 (0.35) PDCD1CD274SMN1; SMN2HTTLTA4H
SCHEMBL4695757 0.88 CD274 (0.39) PDCD1CD274SMN1; SMN2HTT
SCHEMBL12505524 0.87 ALDH1A1 (0.34) SMN1; SMN2HTTALDH1A1
SCHEMBL4694768 0.87 HDAC1 (0.36) SMN1; SMN2LTA4H
SCHEMBL4695736 0.86 ALDH1A1 (0.40) ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1893577-A1 BIPHENYL COMPOUNDS USEFUL AS MUSCARINIC RECEPTOR ANTAGONISTS Theravance, Inc. (US) 2008-03-05 EP claimed
WO-2006138218-A1 BIPHENYL COMPOUNDS USEFUL AS MUSCARINIC RECEPTOR ANTAGONISTS THERAVANCE, INC. (US) 2006-12-28 WO claimed
EP-1893577-A1 BIPHENYL COMPOUNDS USEFUL AS MUSCARINIC RECEPTOR ANTAGONISTS Theravance, Inc. (US) 2008-03-05 EP disclosed
WO-2006138218-A1 BIPHENYL COMPOUNDS USEFUL AS MUSCARINIC RECEPTOR ANTAGONISTS THERAVANCE, INC. (US) 2006-12-28 WO disclosed